Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: Results of a longitudinal study

References 

1. Bowman JM, Chown B, Lewis M, Pollock JM. Rh-isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J. 1978;118:623–627
   • MEDLINE
2. Tovey LA, Townley A, Stevenson BJ, Taverner J. The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae. Lancet. 1983;2:244–246
   • MEDLINE
3. Torrance GW, Zipursky A. Cost-effectiveness of antepartum prevention of Rh immunization. Clin Perinatol. 1982;11:477–480
4. Anti-D immunoglobulin prophylaxis—are we doing enough? Drugs Ther Bull 1985;23:93–5.
5. Lee D, Rawlinson VI. Multicentre trial of antepartum low-dose anti-D immunoglobulin. Transfus Med. 1995;5:15–19
   • MEDLINE
   • CrossRef
6. MacKenzie IZ, Bowell P, Gregory H, Pratt G, Guest C, Entwistle CC. Routine antenatal Rhesus D immunoglobulin prophylaxis: the results of a prospective 10 year study. Brit J Obstet Gynaecol. 1999;106:492–497
7. Mayne S, Parker JH, Harden TA, Dodds SD, Beale JA. Rate of RhD sensitisation before and after implementation of a community based antenatal prophylaxis programme. Brit Med J. 1997;515:1588
8. Thornton JG, Page C, Foote G, Arthur GR, Tovey LA, Scott JS. Efficacy and long term effects of antenatal prophylaxis with anti-D immunoglobulin. Brit Med J. 1989;298:1671–1673
9. Trolle B. Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand. 1989;68:45–47
   • MEDLINE
   • CrossRef
10. National Institute for Clinical Excellence (NICE) . Guidance on the Use of Routine Antenatal Anti-D Prophylaxis for RhD-Negative Women. Technology Appraisal 41. London: National Institute for Clinical Excellence; 2002;
11. Chilcott JB, Lloyd Jones M, Wight J, et al. The review of the clinical effectiveness and cost-effectiveness of routine anti-D prophylaxis for pregnant women who are Rhesus (RhD) negative. Health Technol Assess. 2003;7:1–80
    • MEDLINE
12. McMaster Conference. Proceedings of the McMaster Conference on Prevention of Rh Immunization. Vox Sang 1979;36:50–64.
13. MacKenzie IZ, Selinger M, Bowell PJ. Management of red cell isoimmunization in the 1990s. In:  Studd JWW editors. Progress in Obstetrics and Gynaecology. London: Churchill Livingstone; 1991;p. 31–53